Hansa Biopharma AB (HNSBF)
2.90
0.00 (0.00%)
USD |
OTCM |
May 15, 16:00
Hansa Biopharma Shareholders Equity (Quarterly) : -28.90M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BONESUPPORT HOLDING AB | 98.56M |
| BioInvent International AB | 46.09M |
| BioArctic AB | 213.38M |
| Swedish Orphan Biovitrum AB | 4.238B |
| Egetis Therapeutics AB | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 122.00M |
| Total Liabilities (Quarterly) | 150.89M |
| Debt to Equity Ratio | -4.150 |
| Current Ratio | 3.630 |
| Net Debt Paydown Yield | -1.54% |